The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Hamm Robert A since 2006.
The trader's CIK number is 1335018.
At the time of the last reporting, Hamm Robert A was the EVP, Pharma. Oper. & of Biogen Inc.. (stock ticker symbol BIIB).
Also see all insider trading activities at Biogen Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2010 | BIIB | 0 | $0 | 12,249 | $665,351 | 0 | $0 |
| 2009 | BIIB | 0 | $0 | 13,130 | $642,683 | 5,466 | $0 |
| 2008 | BIIB | 0 | $0 | 166,033 | $11,495,519 | 161,553 | $7,781,667 |
| 2007 | BIIB | 0 | $0 | 14,996 | $706,991 | 5,467 | $0 |
| 2006 | BIIB | 0 | $0 | 16,207 | $693,059 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-04-23 | BIIB | Sale | 5,668 | 52.19 | 295,795 |
| 2010-02-18 | BIIB | Sale | 6,581 | 56.16 | 369,556 |
| 2009-11-04 | BIIB | Sale | 2,854 | 42.82 | 122,208 |
| 2009-06-22 | BIIB | Sale | 3,194 | 50.26 | 160,520 |
| 2009-02-19 | BIIB | Sale | 3,412 | 50.90 | 173,674 |
| 2009-02-11 | BIIB | Sale | 3,670 | 50.76 | 186,281 |
| 2009-02-06 | BIIB | Option Ex | 5,466 | .00 | 0 |
| 2008-11-06 | BIIB | Sale | 2,855 | 44.70 | 127,612 |
| 2008-07-22 | BIIB | Sale | 156,086 | 70.00 | 10,926,020 |
| 2008-07-22 | BIIB | Option Ex | 156,086 | 49.85 | 7,781,667 |
| 2008-04-15 | BIIB | Sale | 3,413 | 63.82 | 217,807 |
| 2008-02-12 | BIIB | Sale | 3,679 | 60.91 | 224,080 |
| 2008-02-06 | BIIB | Option Ex | 5,467 | .00 | 0 |
| 2007-04-23 | BIIB | Sale | 3,731 | 47.34 | 176,629 |
| 2007-03-20 | BIIB | Sale | 5,077 | 44.48 | 225,814 |
| 2007-02-13 | BIIB | Sale | 6,188 | 49.22 | 304,548 |
| 2007-02-06 | BIIB | Option Ex | 5,467 | .00 | 0 |
| 2006-09-19 | BIIB | Sale | 16,207 | 42.76 | 693,059 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hamm Robert A (EVP, Pharma. Oper. & of Biogen Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.